First Clinical SimpliFix Case

Exton, Penn., September 17, 2023 – Stabiliz Orthopaedics announces the first clinical cases using the SimpliFix Hip System. The procedure was completed by board certified, fellowship trained orthopaedic trauma surgeon Anjan R Shah, MD, at Tampa General Hospital in Tampa, FL.

Dr. Shah said, “The procedure was quick and simple, while the instrumentation was slick and easy to use. The cross screw addresses issues with prior methods by controlling shortening, resisting rotation and reducing operative/fluoroscopy time.“

Developed and marketed by StabilizOrtho, SimpliFix utilizes surgeon-controlled compression to resist femoral neck shortening. Maintaining the patient’s natural anatomy and preserving femoral neck length has been shown to improve postoperative pain and functional outcomes.

 Douglas L Cerynik, MD, MBA, co-founder and CEO of StabilizOrtho and SimpliFix co-inventor said, “This is an incredible milestone and significant step towards potentially improving patient outcomes. Our team members worked diligently to develop and launch this product in record time. We went from a singular thought to product launch in 20 months.” Dr Cerynik continued, “We are excited that this product is now in the hands of our clinical partners. We look forward to seeing the clinical data supporting the efficacy of SimpliFix.”

About Stabiliz Orthopaedics:

Stabiliz Orthopaedics, Inc is a medical device innovator that designs and commercializes creative orthopaedic trauma implants. Passionate about improving patient outcomes by improving clinical options, Stabiliz partners with world-renowned surgeons who have a vision to make a difference.

SimpliFix demonstrated an enhanced ability to maintain femoral neck length, while limiting femoral head rotation in preclinical testing. In vitro studies may not be representative of clinical performance.

 Learn more about StabilizOrtho and SimpliFix at www.stabilizortho.com